Cargando…
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
Eradication of tumors by the immune system relies on the efficient activation of a T-cell response. For many years, the main focus of cancer immunotherapy has been on cytotoxic CD8 T-cell. However, stimulation of CD4 helper T cells is critical for the promotion and maintenance of immune memory, thus...
Autores principales: | Mensali, Nadia, Grenov, Amalie, Pati, Niladri Bhusan, Dillard, Pierre, Myhre, Marit Renée, Gaudernack, Gustav, Kvalheim, Gunnar, Inderberg, Else Marit, Bakke, Oddmund, Wälchli, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350688/ https://www.ncbi.nlm.nih.gov/pubmed/30723591 http://dx.doi.org/10.1080/2162402X.2018.1558663 |
Ejemplares similares
-
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019) -
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
por: Mensali, Nadia, et al.
Publicado: (2019) -
NK cells specifically TCR-dressed to kill cancer cells
por: Mensali, Nadia, et al.
Publicado: (2019) -
T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
por: Inderberg, Else M., et al.
Publicado: (2017) -
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
por: Dillard, Pierre, et al.
Publicado: (2021)